AR022150A1 - Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados - Google Patents

Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados

Info

Publication number
AR022150A1
AR022150A1 ARP990106828A ARP990106828A AR022150A1 AR 022150 A1 AR022150 A1 AR 022150A1 AR P990106828 A ARP990106828 A AR P990106828A AR P990106828 A ARP990106828 A AR P990106828A AR 022150 A1 AR022150 A1 AR 022150A1
Authority
AR
Argentina
Prior art keywords
methods
nucleic acids
monocits
related compositions
acids derived
Prior art date
Application number
ARP990106828A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR022150A1 publication Critical patent/AR022150A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se describen ácidos nucleicos que codifican diversas proteínas derivadas de monocitos y composiciones relacionadas, incluyendo proteínas purificadas yanticuerpos específicos. También se proveen métodos para utilizar ese tipo de composicion.
ARP990106828A 1998-12-31 1999-12-29 Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados AR022150A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22460498A 1998-12-31 1998-12-31
US22391998A 1998-12-31 1998-12-31

Publications (1)

Publication Number Publication Date
AR022150A1 true AR022150A1 (es) 2002-09-04

Family

ID=26918252

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106828A AR022150A1 (es) 1998-12-31 1999-12-29 Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados

Country Status (10)

Country Link
US (6) US6774214B1 (es)
EP (2) EP1770160A1 (es)
JP (2) JP4629873B2 (es)
CN (1) CN1352685A (es)
AR (1) AR022150A1 (es)
AT (1) ATE474049T1 (es)
AU (1) AU2710400A (es)
CA (1) CA2358562A1 (es)
DE (1) DE69942594D1 (es)
WO (1) WO2000040721A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105303A1 (en) * 1996-12-06 2003-06-05 Schering Corporation, A New Jersey Corporation Isolated mammalian monocyte cell genes; related reagents
ATE474049T1 (de) 1998-12-31 2010-07-15 Schering Corp Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren
KR100941678B1 (ko) * 2007-12-17 2010-02-12 강원대학교산학협력단 암세포의 전이 억제 활성을 갖는 폴리펩타이드 또는 그의융합 단백질
WO2009085920A1 (en) 2007-12-20 2009-07-09 Schering Corporation Fdf03 antibodies and uses thereof
KR101061016B1 (ko) * 2008-09-17 2011-08-31 강원대학교산학협력단 암세포의 성장 억제 및 염증 질환의 예방 또는 치료활성을 갖는 폴리펩타이드 또는 그의 융합 단백질
EP2432499A2 (en) 2009-05-20 2012-03-28 Schering Corporation Modulation of pilr receptors to treat microbial infections
US8691227B2 (en) 2009-12-17 2014-04-08 Merck Sharp & Dohme Corp. Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-α
EP3070104B1 (en) 2011-04-19 2017-12-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Human monoclonal antibodies specific for glypican-3 and use thereof
KR101927912B1 (ko) * 2016-11-01 2018-12-11 현대자동차주식회사 단말기, 단말기와 통신하는 차량, 단말기와 통신하는 퍼스널 모빌리티, 단말기의 제어 방법 및 차량의 제어 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
DK580789D0 (da) * 1989-11-20 1989-11-20 Novo Nordisk As Fremgangsmaade til oprensning af polypeptider
PT948623E (pt) * 1996-12-06 2010-05-04 Schering Corp Genes de células monócitos de mamífero isolados; reagentes relacionados
WO1998025959A2 (en) * 1996-12-11 1998-06-18 Chiron Corporation Secreted human proteins
WO1998044113A1 (en) * 1997-03-28 1998-10-08 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU9790798A (en) * 1997-10-06 1999-04-27 Millennium Pharmaceuticals, Inc. Signal peptide containing proteins and uses therefor
EP1090118A2 (en) * 1998-06-26 2001-04-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
ATE474049T1 (de) * 1998-12-31 2010-07-15 Schering Corp Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren

Also Published As

Publication number Publication date
US20130230855A1 (en) 2013-09-05
US7932357B2 (en) 2011-04-26
EP1141292A1 (en) 2001-10-10
JP4969638B2 (ja) 2012-07-04
US20100267022A1 (en) 2010-10-21
DE69942594D1 (de) 2010-08-26
US20120009579A1 (en) 2012-01-12
ATE474049T1 (de) 2010-07-15
US6774214B1 (en) 2004-08-10
CN1352685A (zh) 2002-06-05
US8426144B2 (en) 2013-04-23
CA2358562A1 (en) 2000-07-13
JP4629873B2 (ja) 2011-02-09
JP2002534087A (ja) 2002-10-15
EP1770160A1 (en) 2007-04-04
US20040137506A1 (en) 2004-07-15
JP2010068810A (ja) 2010-04-02
WO2000040721A1 (en) 2000-07-13
US8026351B2 (en) 2011-09-27
AU2710400A (en) 2000-07-24
US20150004608A1 (en) 2015-01-01

Similar Documents

Publication Publication Date Title
BR9915679A (pt) Composições e métodos para aumentar a mineralização óssea
CY1112101T1 (el) Νευροτροφικοι παραγοντες
ATE544776T1 (de) Chimäre dna-bindeproteine
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
DE60144145D1 (de) Subtilisin-variante
AR021139A1 (es) Acidos nucleicos y polipeptidos de activadores de la transcripcion y metodos de uso de los mismos
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
ES2193145T3 (es) Proteinas procoagulants quimericas.
DK0746398T3 (da) Antistofrensning
BR9509665A (pt) Composto composições e métodos
DE69815520D1 (de) Ternäres photoinitiatorsystem zum härten von epoxid-polyolharzzusammensetzungen
PT765394E (pt) Lacases myceliophthora purificadas e acidos nucleicos que as codificam
DE69711395D1 (de) Verfahren zur herstellung von cyclohexen-carboxylatderivate
KR950700779A (ko) 단백질의 정제방법(Protein purification)
ATE484587T1 (de) Ldcam genannte moleküle
ATE258598T1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
DE69938240D1 (de) Neuer g-protein-gekoppelter rezeptor
CY1108288T1 (el) Αντισωματα για το αντιγονο κυτταρων langerhans θηλαστικων και χρησεις τους
DK0724637T3 (da) Kortikotropinfrigørende faktor2-receptorer
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
ES2152313T3 (es) Gen grb-3-3, sus variantes y sus utilizaciones.
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
SE9602822D0 (sv) New receptor

Legal Events

Date Code Title Description
FB Suspension of granting procedure